Genetic testing company Dante Genomics and Amazon Web Services (AWS) have collaborated to bring generative AI (GenAI) to the clinical care of patients with genomic diseases.

The collaboration will leverage AWS' Amazon Bedrock platform to build large language models (LLMs) for clinical genomics. The partnership aims to apply genomic data in personalized medicine by enabling access and navigation of genomic reports to extract phenotypes of interest and identify related genetic conditions.

Italy-based Dante Genomics is a worldwide genomics information company that focuses on whole genome sequencing and software utilization. With this platform, the company improves patient outcomes, enhances disease prevention, advances diagnostic capabilities, and enables personalized medicine.